Gene Therapy
Gene therapy delivers a working copy of a gene, or a correction to a faulty one, usually once and for life. Manufacturing the delivery vector is often harder than designing the therapy.
131 stocks
| # | Name | Holding | Trade Value |
Theme Stocks |
% of Portfolio | Status | |
|---|---|---|---|---|---|---|---|
| 26 |
Morgan Stanley
New York
| $1.17B | +$216M | 92 | 0.15% | Increased |
|
| 27 |
Nikko Asset Management Americas
New York
| $1.16B | -$151M | 5 | 4.52% | Reduced |
|
| 28 |
Goldman Sachs
New York
| $1.08B | -$87.7M | 69 | 0.24% | Reduced |
|
| 29 |
Charles Schwab
San Francisco,
California
| $1.05B | +$59M | 57 | 0.35% | Increased |
|
| 30 |
Fisher Asset Management
Camas,
Washington
| $1.04B | +$51.6M | 5 | 0.66% | Increased |
|
| 31 |
Capital Research Global Investors
Los Angeles,
California
| $1.03B | -$878M | 4 | 0.24% | Reduced |
|
| 32 |
Dimensional Fund Advisors
Austin,
Texas
| $985M | +$47.7M | 40 | 0.31% | Increased |
|
| 33 |
CC
Casdin Capital
New York
| $966M | +$70.1M | 12 | 24.53% | Increased |
|
| 34 |
Bank of New York Mellon
New York
| $934M | +$34.5M | 64 | 0.18% | Increased |
|
| 35 |
Citadel Advisors
Miami,
Florida
| $918M | +$139M | 80 | 0.21% | Increased |
|
| 36 |
Norges Bank
Oslo,
Norway
| $909M | +$45.5M | 26 | 0.2% | Increased |
|
| 37 |
Perceptive Advisors
New York
| $908M | -$56.1M | 14 | 11.79% | Reduced |
|
| 38 |
Wells Fargo
San Francisco,
California
| $870M | -$64.7M | 77 | 0.19% | Reduced |
|
| 39 |
Ameriprise
Minneapolis,
Minnesota
| $850M | -$19M | 31 | 0.26% | Reduced |
|
| 40 |
Aristotle Capital Management
Los Angeles,
California
| $736M | +$14M | 1 | 1.41% | Increased |
|
| 41 |
Nuveen
Charlotte,
North Carolina
| $727M | +$34.6M | 48 | 0.22% | Increased |
|
| 42 |
Sumitomo Mitsui Trust Group
Minato-Ku, Tokyo,
Japan
| $724M | -$78.2M | 8 | 0.43% | Reduced |
|
| 43 |
Credit Suisse
Zurich,
Switzerland
| $645M | +$24.8M | 37 | 0.34% | Increased |
|
| 44 |
AllianceBernstein
Nashville,
Tennessee
| $638M | -$79.3M | 45 | 0.26% | Reduced |
|
| 45 |
RA Capital Management
Boston,
Massachusetts
| $611M | +$14.4M | 10 | 9.81% | Increased |
|
| 46 |
Macquarie Group
Sydney, NSW 2000,
Australia
| $588M | +$267M | 35 | 0.48% | Increased |
|
| 47 |
Massachusetts Financial Services
Boston,
Massachusetts
| $587M | +$35.9M | 5 | 0.17% | Increased |
|
| 48 |
AG
Artal Group
Luxembourg
| $579M | +$9.79M | 20 | 11.76% | Increased |
|
| 49 |
Two Sigma Advisers
New York
| $576M | +$95.1M | 40 | 1.52% | Increased |
|
| 50 |
Boston Partners
Boston,
Massachusetts
| $575M | +$39.1M | 1 | 0.73% | Increased |
|